Cargando…

Targeting TREM1 augments antitumor T cell immunity by inhibiting myeloid-derived suppressor cells and restraining anti–PD-1 resistance

The triggering receptor expressed on myeloid cell 1 (TREM1) plays a critical role in development of chronic inflammatory disorders and the inflamed tumor microenvironment (TME) associated with most solid tumors. We examined whether loss of TREM1 signaling can abrogate the immunosuppressive TME and e...

Descripción completa

Detalles Bibliográficos
Autores principales: Ajith, Ashwin, Mamouni, Kenza, Horuzsko, Daniel D., Musa, Abu, Dzutsev, Amiran K., Fang, Jennifer R., Chadli, Ahmed, Zhu, Xingguo, Lebedyeva, Iryna, Trinchieri, Giorgio, Horuzsko, Anatolij
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617775/
https://www.ncbi.nlm.nih.gov/pubmed/37651197
http://dx.doi.org/10.1172/JCI167951

Ejemplares similares